Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Suvorexant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Early research (Phase 1)Study completedNCT03158025
What this trial is testing

Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users

Who this might be right for
Insomnia Disorders
Eisai Inc. 39
Post-approval studies (Phase 4)WithdrawnNCT06834386
What this trial is testing

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Who this might be right for
Advanced Malignant Solid NeoplasmDeliriumHematopoietic and Lymphatic System Neoplasm+1 more
Mayo Clinic
Early research (Phase 1)Study completedNCT01311882
What this trial is testing

Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)

Who this might be right for
Insomnia
Merck Sharp & Dohme LLC 28
Testing effectiveness (Phase 2)Looking for participantsNCT05546554
What this trial is testing

Trial of Suvorexant for Sleep in Children With Autism

Who this might be right for
AutismAutism Spectrum Disorder
Stanford University 26
Testing effectiveness (Phase 2)Looking for participantsNCT07214207
What this trial is testing

Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking

Who this might be right for
Alcohol Use Disorder
Ohio State University 250
Testing effectiveness (Phase 2)Study completedNCT00792298
What this trial is testing

Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)

Who this might be right for
Primary Insomnia
Merck Sharp & Dohme LLC 254
Post-approval studies (Phase 4)Study completedNCT03110315
What this trial is testing

Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia

Who this might be right for
Multiple SclerosisFatigueInsomnia
Theodore R. Brown, MD MPH 36
Testing effectiveness (Phase 2)Study completedNCT05908526
What this trial is testing

Insomnia Treatment and EMA (Ecological Momentary Assessment) Outcomes

Who this might be right for
Insomnia
University of Maryland, Baltimore 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT07686731
What this trial is testing

Suvorexant 3 - PE-PC

Who this might be right for
PTSD - Post Traumatic Stress DisorderInsomniaTBI (Traumatic Brain Injury)
Northern California Institute of Research and Education 142
Post-approval studies (Phase 4)Study completedNCT02849548
What this trial is testing

Suvorexant and Sleep's Benefits to Therapeutic Exposure for Posttraumatic Stress Disorder

Who this might be right for
Posttraumatic Stress Disorder
Howard University 27
Large-scale testing (Phase 3)Study completedNCT04571944
What this trial is testing

Efficacy and Safety of Suvorexant (MK-4305) for Reducing Incidence of Delirium in Japanese Participants at High Risk of Delirium (MK-4305-085)

Who this might be right for
Delirium
Merck Sharp & Dohme LLC 207
Large-scale testing (Phase 3)Looking for participantsNCT06655883
What this trial is testing

Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)

Who this might be right for
Insomnia
Merck Sharp & Dohme LLC 300
Post-approval studies (Phase 4)Study completedNCT02491788
What this trial is testing

Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers

Who this might be right for
Sleep Disorder, Shift-Work
VA Palo Alto Health Care System 19
Very early researchStudy completedNCT05656534
What this trial is testing

Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder

Who this might be right for
Alcohol Use Disorder
Ohio State University 81
Post-approval studies (Phase 4)Ended earlyNCT06162663
What this trial is testing

Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors

Who this might be right for
Breast CancerInsomnia
Medical University of South Carolina 6
Post-approval studies (Phase 4)Study completedNCT03034018
What this trial is testing

Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia

Who this might be right for
Insomnia
Brigham and Women's Hospital 60